These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance? Smittenaar P; Chase HW; Aarts E; Nusselein B; Bloem BR; Cools R Eur J Neurosci; 2012 Apr; 35(7):1144-51. PubMed ID: 22487043 [TBL] [Abstract][Full Text] [Related]
25. The effect of dopamine on conditioned placebo analgesia in healthy individuals: a double-blind randomized trial. Zunhammer M; Gerardi M; Bingel U Psychopharmacology (Berl); 2018 Sep; 235(9):2587-2595. PubMed ID: 29943093 [TBL] [Abstract][Full Text] [Related]
26. A shift of paradigm: from noradrenergic to dopaminergic modulation of learning? Breitenstein C; Flöel A; Korsukewitz C; Wailke S; Bushuven S; Knecht S J Neurol Sci; 2006 Oct; 248(1-2):42-7. PubMed ID: 16815467 [TBL] [Abstract][Full Text] [Related]
27. Modulation of habit formation by levodopa in Parkinson's disease. Marzinzik F; Wotka J; Wahl M; Krugel LK; Kordsachia C; Klostermann F PLoS One; 2011; 6(11):e27695. PubMed ID: 22110725 [TBL] [Abstract][Full Text] [Related]
28. An electromyographic analysis of the effect of levodopa on the response time of healthy subjects. Hasbroucq T; Tandonnet C; Micallef-Roll J; Blin O; Possamaï CA Psychopharmacology (Berl); 2003 Jan; 165(3):313-6. PubMed ID: 12451441 [TBL] [Abstract][Full Text] [Related]
29. Age at Parkinson's disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task. Waldthaler J; Stock L; Krüger-Zechlin C; Timmermann L Neuropsychologia; 2021 Dec; 163():108082. PubMed ID: 34728241 [TBL] [Abstract][Full Text] [Related]
30. Modulatory effects of levodopa on cognitive control in young but not in older subjects: a pharmacological fMRI study. Onur ÖA; Piefke M; Lie CH; Thiel CM; Fink GR J Cogn Neurosci; 2011 Oct; 23(10):2797-810. PubMed ID: 21254797 [TBL] [Abstract][Full Text] [Related]
31. Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson's Disease: A Pilot Study. Volpato C; Schiff S; Facchini S; Silvoni S; Cavinato M; Piccione F; Antonini A; Birbaumer N Front Behav Neurosci; 2016; 10():205. PubMed ID: 27822182 [TBL] [Abstract][Full Text] [Related]
32. Neither Cholinergic Nor Dopaminergic Enhancement Improve Spatial Working Memory Precision in Humans. Harewood Smith AN; Challa JA; Silver MA Front Neural Circuits; 2017; 11():94. PubMed ID: 29259546 [TBL] [Abstract][Full Text] [Related]
33. Dopaminergic influences on formation of a motor memory. Flöel A; Breitenstein C; Hummel F; Celnik P; Gingert C; Sawaki L; Knecht S; Cohen LG Ann Neurol; 2005 Jul; 58(1):121-30. PubMed ID: 15984008 [TBL] [Abstract][Full Text] [Related]
34. Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson's activity. Gluck MR; Santana LA; Granson H; Yahr MD J Neural Transm (Vienna); 2004 Jun; 111(6):713-24. PubMed ID: 15168218 [TBL] [Abstract][Full Text] [Related]
36. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
37. Levodopa and the progression of Parkinson's disease. Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952 [TBL] [Abstract][Full Text] [Related]
38. Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinson's disease. Moustafa AA; Herzallah MM; Gluck MA Neurodegener Dis; 2013; 11(2):102-11. PubMed ID: 23128796 [TBL] [Abstract][Full Text] [Related]
39. Dopaminergic modulation of response inhibition: an fMRI study. Hershey T; Black KJ; Hartlein J; Braver TS; Barch DM; Carl JL; Perlmutter JS Brain Res Cogn Brain Res; 2004 Aug; 20(3):438-48. PubMed ID: 15268921 [TBL] [Abstract][Full Text] [Related]
40. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease. van Wouwe NC; Ridderinkhof KR; Band GP; van den Wildenberg WP; Wylie SA Neuropsychologia; 2012 Apr; 50(5):583-91. PubMed ID: 22223079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]